Central Trust CO Ionis Pharmaceuticals Inc Transaction History

Central Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 14, 2020	SELL	$46.85 - $61.05 $2,811 - $3,663	-60 Closed	0 $0
Q2 2019 Jul 12, 2019	BUY	$62.09 - $86.14 $3,725 - $5,168	60 New	60 $0
Q2 2018 Jul 09, 2018	SELL	$40.53 - $50.7 $8,106 - $10,140	-200 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$45.56 - $59.57 $9,112 - $11,914	200	200 $0

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.1B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Trust CO with notifications on news.